NCT03259035 - NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 29, 2018

Primary Completion Date

April 8, 2024

Study Completion Date

April 25, 2024

Conditions

Rectal Cancer

Interventions

DRUG

Folfox Protocol

6 cycles of q2weekly FOLFOX, or

DRUG

Capox

4 cycles of q3weekly CAPOX

Trial Locations (11)

UC Irvine Medical Center, Orange

Virginia Mason Medical Center, Seattle

Dana-Farber Cancer Institute, Boston

BCCA - Vancouver Cancer Centre, Vancouver

St. Paul's Hospital, Vancouver

CancerCare Manitoba, Winnipeg

QEII Health Sciences Centre, Halifax

Health Sciences North, Greater Sudbury

Kingston Health Sciences Centre, Kingston

Ottawa Hospital Research Institute, Ottawa

The Research Institute of the McGill University, Montreal

All Listed Sponsors

lead

Canadian Cancer Trials Group

NETWORK